Last Update

This profile was last updated on 10/7/2017 and contains contributions from the  ZoomInfo Community.

is this you? Claim your profile.

Wrong ReGen Biologics?

ReGen Biologics

Ivy Sports Medicine LLC

HQ Phone:  (201) 573-8400

Get Zoominfo Grow
Community Edition

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    the Plugin
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check Your Inbox to
    Sign Up for ZoomInfo Community Edition

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Ivy Sports Medicine LLC

102 Chestnut Ridge Rd suite 204

Montvale, New Jersey, 07645

United States

Company Description

Ivy Sports Medicine ("ISM") was formed in February of 2011 to create a global healthcare company focused on providing the best sports medicine therapies for orthopedic surgeons and patients. In June 2011, ISM acquired assets from ReGen Biologics out of Chapter...more

Find other employees at this company (28)

Web References(27 Total References)


Management Team | Ivy Sports Medicine

Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc.
Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs. As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products. He holds a B.A. in biological science from Columbia College.


Management Team | Ivy Sports Medicine

Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc.
Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs. As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products. He holds a B.A. in biological science from Columbia College. Mr. Bailey has worked in and run sales organizations focusing in Sports Medicine, Biologics, Joint Replacement and Spinal Implants.


Management Team | Ivy Sports Medicine

Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc.
Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs. As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products. He holds a B.A. in biological science from Columbia College.


http://www.medcitynews.com/2011/06/cardiac-medical-device-company-thoratec-loses-cfo-david-smith/

ReGen Biologics terminates stock after suing FDA


Corporate Overview | Ivy Sports Medicine

In June 2011, Ivy Sports Medicine aquired assets from ReGen Biologics out of Chapter 11.
The production facility for the Collagen Meniscus Implant (CMI®) was maintained, including the employees.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory